Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial (LIBERTY AD ADOL). J of Skin 2020, 4 (5), s51. https://doi.org/10.25251/skin.4.supp.50.